Skip to main content

Table 1 Clinical pathological parameters of Asian patients with gastrointestinal cancer in this research

From: Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population

Tumor type Clinical characteristic   N (%)
Liver hepatocellular carcinoma (LIHC) Age (years)  > 65 36 (22.78)
    ≤ 65 122 (77.22)
  Gender Male 124 (78.48)
   Female 34 (21.52)
  Stage I–II stage 151 (95.57)
   III–IV stage 7 (4.43)
  Vital status Alive 114 (72.15)
   Dead 44 (27.85)
Stomach adenocarcinoma (STAD) Age (years)  > 65 41 (55.41)
    ≤ 65 33 (44.59)
  Gender Male 49 (66.22)
   Female 25 (33.78)
  Stage I- II stage 43 (58.11)
   III–IV stage 29 (39.19)
   Not reported 2 (2.70)
  Vital status Alive 54 (72.97)
   Dead 19 (25.68)
   Not reported 1 (1.35)
Esophageal carcinoma (ESCA) Age (years)  > 65 6 (15.79)
    ≤ 65 32 (84.21)
  Gender Male 35 (92.11)
   Female 3 (7.89)
  Stage I–II stage 11 (28.95)
   III–IV stage 6 (15.79)
   Not reported 21 (55.26)
  Vital status Alive 31 (81.58)
   Dead 7 (18.42)
Pancreatic adenocarcinoma (PAAD) Age (years)  > 65 4 (36.36)
    ≤ 65 7 (63.64)
  Gender Male 5 (45.45)
   Female 6 (54.55)
  Stage I–II stage 11 (100.00)
   III–IV stage 0 (0.00)
  Vital status Alive 6 (54.55)
   Dead 5 (45.45)
Colon adenocarcinoma (COAD) Age (years)  > 65 2 (18.18)
    ≤ 65 9 (81.82)
  Gender Male 8 (72.73)
   Female 3 (27.27)
  Stage I–II stage 10 (90.91)
   III–IV stage 1 (9.09)
  Vital status Alive 9 (81.82)
   Dead 2 (18.18)
Cholangiocarcinoma (CHOL) Age (years)  > 65 2 (66.67)
    ≤ 65 1 (33.33)
  Gender Male 2 (66.67)
   Female 1 (33.33)
  Stage I–II stage 3 (100.00)
   III–IV stage 0 (0.00)
  Vital status Alive 1 (33.33)
   Dead 2 (66.67)
Rectum adenocarcinoma (READ) Age (years)  > 65 0 (0.00)
    ≤ 65 1 (100.00)
  Gender Male 1 (100.00)
   Female 0 (0.00)
  Stage I–II stage 1 (100.00)
   III–IV stage 0 (0.00)
  Vital status Alive 1 (100.00)
   Dead 0 (0.00)
\